| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | 462-TR-010/CF | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | 6449-TEC-010/CF | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | 462-TEC-010/CF | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-56512SS | |||
| Azide and BSA Free | NB100-56593SS | |||
| Azide and BSA Free | NB100-56593 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | 390-TN-010/CF | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF462-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-27402 | |||
| BSA Free | NB100-56748SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB626-SP | |||
| Carrier Free | MAB626-500 | |||
![TRANCE/TNFSF11/RANK L [HRP]](http://images.novusbio.com/fullsize2/DATA_TRANCE_MTR00_ELISA_1043.jpg "TRANCE/TNFSF11/RANK L [HRP]")
![TRANCE/TNFSF11/RANK L [HRP]](http://images.novusbio.com/fullsize2/TRANCE_MTR00_ELISA_330.jpg)
![Immunohistochemistry: TRANCE/TNFSF11/RANK L Antibody (12A668) [NB100-56512] - MQDL detects EMT biomarkers in clinical prostate cancer. EMT biomarkers (EpCAM, N-Cad, and RANKL)were detected in a clinical primary prostate cancer specimen (Gleason score 6; 3+3) with documented bone metastasis. M denotes cells that completed EMT and E/M indicates cells undergoing partial EMT. 400x. Image collected and cropped by CiteAb from the following publication (//journals.plos.org/plosone/article?id=10.1371/journal.pone.0028670) licensed under a CC-BY licence.](http://images.novusbio.com/fullsize2/TRANCE-TNFSF11-RANK-L-Antibody-(12A668)-Immunohistochemistry-NB100-56512-img0019.jpg "Immunohistochemistry: TRANCE/TNFSF11/RANK L Antibody (12A668) [NB100-56512] - MQDL detects EMT biomarkers in clinical prostate cancer. EMT biomarkers (EpCAM, N-Cad, and RANKL)were detected in a clinical primary prostate cancer specimen (Gleason score 6; 3+3) with documented bone metastasis. M denotes cells that completed EMT and E/M indicates cells undergoing partial EMT. 400x. Image collected and cropped by CiteAb from the following publication (//journals.plos.org/plosone/article?id=10.1371/journal.pone.0028670) licensed under a CC-BY licence."){kind=icon}
![Western Blot: TRANCE/TNFSF11/RANK L Antibody (12A668) [NB100-56512] - Analysis using Azide Free version of NB100-56512. Human lymph node lysate (35ug per lane, RIPA buffer). Band detected at ~35kDa and ~28kDa. (Expected MW of 35.5kDa according to NP_003692.1 and of 27.7kDa according to NP_143026.1)](http://images.novusbio.com/fullsize2/TRANCE-TNFSF11-RANK-L-Antibody-(12A668)-Western-Blot-NB100-56512-img0016.jpg){kind=icon}
![Immunocytochemistry/Immunofluorescence: TRANCE/TNFSF11/RANK L Antibody (12A668) [NB100-56512] - TRANCE was detected in immersion fixed mouse splenocytes using anti-human/mouse/rat mouse monoclonal antibody (Catalog # NB100-56512) for 1 hour at room temperature. Cells were stained using NL557 (red) fluorescent anti-mouse secondary antibodies (Catalog # NL007) and counterstained with DAPI (blue).](http://images.novusbio.com/fullsize2/TRANCE-TNFSF11-RANK-L-Antibody-(12A668)-Immunocytochemistry-Immunofluorescence-NB100-56512-img0018.jpg){kind=icon}
![Immunohistochemistry: TRANCE/TNFSF11/RANK L Antibody (12A668) [NB100-56512] - MQDL detects EMT biomarkers in clinical bone tissue specimens. A representative specimen of human prostate cancer bone metastasis co-expressed high levels of epithelial EpCAM, and mesenchymal RANKL and vimentin proteins. 400x. Image collected and cropped by CiteAb from the following publication (//journals.plos.org/plosone/article?id=10.1371/journal.pone.0028670) licensed under a CC-BY licence.](http://images.novusbio.com/fullsize2/TRANCE-TNFSF11-RANK-L-Antibody-(12A668)-Immunohistochemistry-NB100-56512-img0020.jpg){kind=icon}
![Western Blot: TRANCE/TNFSF11/RANK L Antibody (12A668) [NB100-56512] - Analysis of transfected cell lysate was probed with TRANCE/TNFSF11/RANK L antibody.](http://images.novusbio.com/fullsize2/TRANCE-TNFSF11-RANK-L-Antibody-(12A668)-Western-Blot-NB100-56512-img0013.jpg){kind=icon}
![Immunohistochemistry-Paraffin: TRANCE/TNFSF11/RANK L Antibody (12A668) [NB100-56512] - Analysis using Azide Free version of NB100-56512. FFPE human liver stained with TRANCE/TNFSF11/RANK L antibody, peroxidase-conjugate and DAB chromogen. A 2 hr incubation at RT was used.](http://images.novusbio.com/fullsize2/TRANCE-TNFSF11-RANK-L-Antibody-(12A668)-Immunohistochemistry-Paraffin-NB100-56512-img0014.jpg){kind=icon}
![Immunohistochemistry-Paraffin: TRANCE/TNFSF11/RANK L Antibody (12A668) [NB100-56512] - Analysis using Azide Free version of NB100-56512. FFPE human lymph node probed with TRANCE/TNFSF11/RANK L antibody.](http://images.novusbio.com/fullsize2/TRANCE-TNFSF11-RANK-L-Antibody-(12A668)-Immunohistochemistry-Paraffin-NB100-56512-img0015.jpg){kind=icon}
![TRANCE/TNFSF11/RANK L [Biotin]](http://images.novusbio.com/fullsize2/DATA_TRANCE_DY626_ELISA_2158.jpg "TRANCE/TNFSF11/RANK L [Biotin]")
![Western Blot: TRANCE/TNFSF11/RANK L Antibody (12A380) [NB100-56748] - Analysis of recombinant RANKL (partial) probed with RANKL antibody at 1 ug/ml.](http://images.novusbio.com/fullsize2/TRANCE-TNFSF11-RANK-L-Antibody-(12A380)-Western-Blot-NB100-56748-img0002.jpg "Western Blot: TRANCE/TNFSF11/RANK L Antibody (12A380) [NB100-56748] - Analysis of recombinant RANKL (partial) probed with RANKL antibody at 1 ug/ml."){kind=icon}
![Immunohistochemistry-Paraffin: TRANCE/TNFSF11/RANK L Antibody (12A380) [NB100-56748] - Analysis of FFPE human tonsil using TRANCE (12A380) antibody at 1:50 on a Bond Rx autostainer (Leica Biosystems). The assay involved 20 minutes of heat induced antigen retrieval (HIER) using 10mM sodium citrate buffer (pH 6.0) and endogenous peroxidase quenching with peroxide block. The sections were incubated with primary antibody for 30 minutes and Bond Polymer Refine Detection (Leica Biosystems) with DAB was used for signal development followed by counterstaining with hematoxylin. Whole slide scanning and capturing of representative images was performed using Aperio AT2 (Leica Biosystems). Cytoplasmic staining was observed. Staining was performed by Histowiz.](http://images.novusbio.com/fullsize2/TRANCE-TNFSF11-RANK-L-Antibody-(12A380)-Immunohistochemistry-Paraffin-NB100-56748-img0010.jpg){kind=icon}
![Flow Cytometry: TRANCE/TNFSF11/RANK L Antibody (12A380) [NB100-56748] - Analysis using the Alexa Fluor (R) 647 conjugate of NB100-56748. Staining of RANKL in untreated mouse splenocytes (green) and 72 hour ConA-stimulated mouse splenocytes (red) using this antibody. 1 ug of RANKL antibody was used for this assay.](http://images.novusbio.com/fullsize2/TRANCE-TNFSF11-RANK-L-Antibody-(12A380)-Flow-Cytometry-NB100-56748-img0006.jpg){kind=icon}
![Immunohistochemistry-Frozen: TRANCE/TNFSF11/RANK L Antibody (12A380) [NB100-56748] - Analysis in RAW cells using 2 ug of antibody. Shaded histogram represents cells without antibody; green represents isotype control antibody; purple represents antibody. Image using the PE format of this antibody.](http://images.novusbio.com/fullsize2/TRANCE-TNFSF11-RANK-L-Antibody-(12A380)-Immunohistochemistry-Frozen-NB100-56748-img0011.jpg){kind=icon}
![Flow Cytometry: TRANCE/TNFSF11/RANK L Antibody (12A380) [NB100-56748] - Analysis using the Alexa Fluor (R) 488 conjugate of NB100-56748. Staining of RANKL in untreated mouse splenocytes (green) and 72 hour ConA-stimulated mouse splenocytes (red) using this antibody. 1 ug of RANKL antibody was used for this assay.](http://images.novusbio.com/fullsize2/TRANCE-TNFSF11-RANK-L-Antibody-(12A380)-Flow-Cytometry-NB100-56748-img0005.jpg){kind=icon}
![TRANCE/TNFSF11/RANK L [Biotin]](http://images.novusbio.com/fullsize2/DATA_TRANCE_DY462_ELISA_2045.jpg "TRANCE/TNFSF11/RANK L [Biotin]")
![Western Blot: TRANCE/TNFSF11/RANK L Antibody - BSA Free [NB100-80849] - Rat liver tissue lysate with sRANK-L antibody at (A) 0.25 and (B) 0.5 ug/ml.](http://images.novusbio.com/fullsize2/TRANCE-TNFSF11-RANK-L-Antibody---BSA-Free-Western-Blot-NB100-80849-img0011.jpg "Western Blot: TRANCE/TNFSF11/RANK L Antibody - BSA Free [NB100-80849] - Rat liver tissue lysate with sRANK-L antibody at (A) 0.25 and (B) 0.5 ug/ml."){kind=icon}
![Immunohistochemistry-Paraffin: TRANCE/TNFSF11/RANK L Antibody - BSA Free [NB100-80849] - Staining of human small intestine tissue after heat-induced antigen retrieval. Antibody concentration 5 ug/ml.](http://images.novusbio.com/fullsize2/TRANCE-TNFSF11-RANK-L-Antibody---BSA-Free-Immunohistochemistry-Paraffin-NB100-80849-img0007.jpg){kind=icon}
![Immunohistochemistry-Paraffin: TRANCE/TNFSF11/RANK L Antibody - BSA Free [NB100-80849] - Staining of human breast tissue after heat-induced antigen retrieval. Antibody concentration 5 ug/ml.](http://images.novusbio.com/fullsize2/TRANCE-TNFSF11-RANK-L-Antibody---BSA-Free-Immunohistochemistry-Paraffin-NB100-80849-img0005.jpg){kind=icon}